[57] FDA explains that the MAUDE database is a passive surveillance system, and that incidence, prevalence, or cause of an event cannot be determined from this surveillance system alone due to under-reporting of events, inaccuracies in reports, lack of verification that the device caused the reported event, and lack of information about frequency of device use
reputable providers will not prescribe it simply for wellness in a person with normal hormones
Because the new technology service was not separately paid in this scenario, the overall number of single claims available to determine an appropriate clinical APC for the new service was reduced
Patients should also contact their provider if they experience symptoms of hypoglycemia (low blood sugar), particularly if taking semaglutide with insulin or sulfonylureas
In Western societies, consumption patterns have a significant environmental footprint, yet only a small proportion of consumers prioritize seasonal and locally produced food